Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Stockholders' Equity (Details Narrative)

v3.21.1
Note 7 - Stockholders' Equity (Details Narrative) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Stockholders' Deficit:    
Common stock, authorized 2,000,000,000 2,000,000,000
Common stock, par value $ 0.001 $ 0.001
Preferred stock, authorized 15,000,000 15,000,000
Preferred stock, par value $ 0.01 $ 0.01
Common stock, issued 20,517,431 5,218,122
Common stock, outstanding 20,517,431 5,218,122
Stockbased compensation to be recognized $ 2,440,000  
Intrinsic value of warrants $ 7,415,000